Exhibit 99.1
------------
Joint Filing Agreement
The undersigned hereby agree that the statement on Schedule 13G with
respect to the common stock of Replidyne, Inc. is, and any amendment thereto
signed by each of the undersigned shall be, filed on behalf of each undersigned
pursuant to and in accordance with the provisions of 13d-1(k) under the
Securities Exchange Act of 1934 and that all subsequent amendments to this
statement on Schedule 13G shall be filed on behalf of each of the undersigned
without the necessity of filing additional joint filing agreements. The
undersigned acknowledge that each shall be responsible for the timely filing of
such amendments, and for the completeness and accuracy of the information
concerning it contained therein, but shall not be responsible for the
completeness and accuracy of the information concerning the other, except to the
extent that it knows or has reason to believe that such information is
inaccurate.
DATED: July 7, 2006
DUQUESNE CAPITAL MANAGEMENT, L.L.C.
By: /s/ Xxxxxx Xxxxxx
----------------------------
Name: Xxxxxx Xxxxxx
Title: Managing Director
XXXXXXX X. XXXXXXXXXXXXX
By: /s/ Xxxxxx Xxxxxx
----------------------------
Name: Xxxxxx Xxxxxx
Title: Attorney-in-Fact
WINDMILL MASTER FUND L.P.
By: Duquesne Capital Management, L.L.C.,
its investment manager
By: /s/ Xxxxxx Xxxxxx
----------------------------
Name: Xxxxxx Xxxxxx
Title: Managing Director